RETURN TO COMPANIES

Silico Therapeutics

Founded By
Alexendar Pérez

Improving CRISPR specificity (i.e. reducing adverse outcomes)

Silico Therapeutics

Improving CRISPR specificity (i.e. reducing adverse outcomes)

FOUNDERS

Alexendar
I am CEO of Silico Therapeutics. My speciality is in software development for CRISPR target specificity. I hold a Ph.D in computer science. I hold an M.D.

OTHER INVESTORS

No items found.